Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Top Cited Papers
- 20 May 2008
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 51 (21) , 2028-2033
- https://doi.org/10.1016/j.jacc.2008.04.002
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary InterventionCirculation, 2007
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2007
- Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose ClopidogrelJournal of Cardiovascular Pharmacology, 2007
- ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency MedicinePublished by Elsevier ,2007
- Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of PhysiciansCatheterization and Cardiovascular Interventions, 2007
- Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery StentsJournal of the American College of Cardiology, 2007
- Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohortAmerican Heart Journal, 2007
- Clopidogrel and Bleeding After Coronary Artery Bypass Graft SurgeryThe Annals of Thoracic Surgery, 2005
- Variability in platelet responsiveness to clopidogrel among 544 individualsJournal of the American College of Cardiology, 2005
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial InfarctionJournal of the American College of Cardiology, 2004